Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110113280> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2110113280 endingPage "272" @default.
- W2110113280 startingPage "265" @default.
- W2110113280 abstract "Interferon has antiproliferative and antiangiogenic properties. We sought to evaluate preliminary efficacy and determine the recommended phase II dose (RP2D) for pegylated interferon-α-2b (PI) in patients with unresectable progressive or symptomatic plexiform neurofibromas (PN).PI was administered weekly in cohorts of 3-6 patients during the dose-finding phase and continued for up to 2 years. Twelve patients were treated at the RP2D to further evaluate toxicity and activity.Thirty patients (median age 9.3 years, range 1.9-34.7 years) were enrolled. No dose-limiting toxicity (DLT) was seen in patients treated at the 3 μg/kg dose level (DL) during the first 4 weeks. All 5 patients treated at the 4.5 μg/kg DL came off study or required dose reductions for behavioral toxicity or fatigue. Similar DLT on the 3 μg/kg DL became apparent over time. There was 1 DLT (myoclonus) in 12 patients enrolled at the 1.0 μg/kg DL. Eleven of 16 patients with pain showed improvement and 13 of 14 patients with a palpable mass had a decrease in size. Five of 17 patients (29%) who underwent volumetric analysis had a 15%-22% decrease in volume. Three of 4 patients with documented radiographic progression prior to enrollment showed stabilization or shrinkage.The RP2D of PI for pediatric patients with PN is 1 μg/kg/wk. Clinical and radiographic improvement and cessation of growth can occur.This study provides Class III evidence that pegylated interferon-α-2b in patients with unresectable, progressive, symptomatic, or life-threatening PNs results in radiographic reduction or stabilization of PN size." @default.
- W2110113280 created "2016-06-24" @default.
- W2110113280 creator A5026714103 @default.
- W2110113280 creator A5032059835 @default.
- W2110113280 creator A5055973779 @default.
- W2110113280 creator A5071378074 @default.
- W2110113280 creator A5071679104 @default.
- W2110113280 creator A5080784534 @default.
- W2110113280 creator A5091159537 @default.
- W2110113280 date "2011-01-17" @default.
- W2110113280 modified "2023-10-13" @default.
- W2110113280 title "Phase I trial of pegylated interferon- -2b in young patients with plexiform neurofibromas" @default.
- W2110113280 cites W1558828789 @default.
- W2110113280 cites W1857696541 @default.
- W2110113280 cites W1972615559 @default.
- W2110113280 cites W1975107570 @default.
- W2110113280 cites W1990435553 @default.
- W2110113280 cites W2009733797 @default.
- W2110113280 cites W2033694212 @default.
- W2110113280 cites W204022592 @default.
- W2110113280 cites W2043627490 @default.
- W2110113280 cites W2059964588 @default.
- W2110113280 cites W2063336523 @default.
- W2110113280 cites W2093915058 @default.
- W2110113280 cites W2119410640 @default.
- W2110113280 cites W2123289037 @default.
- W2110113280 cites W2124749544 @default.
- W2110113280 cites W2131532433 @default.
- W2110113280 cites W2145119189 @default.
- W2110113280 cites W2154215865 @default.
- W2110113280 cites W2163253596 @default.
- W2110113280 cites W2332630894 @default.
- W2110113280 cites W2340893063 @default.
- W2110113280 doi "https://doi.org/10.1212/wnl.0b013e318207b031" @default.
- W2110113280 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3034394" @default.
- W2110113280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21242495" @default.
- W2110113280 hasPublicationYear "2011" @default.
- W2110113280 type Work @default.
- W2110113280 sameAs 2110113280 @default.
- W2110113280 citedByCount "50" @default.
- W2110113280 countsByYear W21101132802012 @default.
- W2110113280 countsByYear W21101132802013 @default.
- W2110113280 countsByYear W21101132802014 @default.
- W2110113280 countsByYear W21101132802015 @default.
- W2110113280 countsByYear W21101132802016 @default.
- W2110113280 countsByYear W21101132802017 @default.
- W2110113280 countsByYear W21101132802020 @default.
- W2110113280 countsByYear W21101132802021 @default.
- W2110113280 countsByYear W21101132802022 @default.
- W2110113280 countsByYear W21101132802023 @default.
- W2110113280 crossrefType "journal-article" @default.
- W2110113280 hasAuthorship W2110113280A5026714103 @default.
- W2110113280 hasAuthorship W2110113280A5032059835 @default.
- W2110113280 hasAuthorship W2110113280A5055973779 @default.
- W2110113280 hasAuthorship W2110113280A5071378074 @default.
- W2110113280 hasAuthorship W2110113280A5071679104 @default.
- W2110113280 hasAuthorship W2110113280A5080784534 @default.
- W2110113280 hasAuthorship W2110113280A5091159537 @default.
- W2110113280 hasBestOaLocation W21101132802 @default.
- W2110113280 hasConcept C126322002 @default.
- W2110113280 hasConcept C141071460 @default.
- W2110113280 hasConcept C29730261 @default.
- W2110113280 hasConcept C71924100 @default.
- W2110113280 hasConcept C90924648 @default.
- W2110113280 hasConceptScore W2110113280C126322002 @default.
- W2110113280 hasConceptScore W2110113280C141071460 @default.
- W2110113280 hasConceptScore W2110113280C29730261 @default.
- W2110113280 hasConceptScore W2110113280C71924100 @default.
- W2110113280 hasConceptScore W2110113280C90924648 @default.
- W2110113280 hasIssue "3" @default.
- W2110113280 hasLocation W21101132801 @default.
- W2110113280 hasLocation W21101132802 @default.
- W2110113280 hasLocation W21101132803 @default.
- W2110113280 hasLocation W21101132804 @default.
- W2110113280 hasOpenAccess W2110113280 @default.
- W2110113280 hasPrimaryLocation W21101132801 @default.
- W2110113280 hasRelatedWork W1506200166 @default.
- W2110113280 hasRelatedWork W1995515455 @default.
- W2110113280 hasRelatedWork W2048182022 @default.
- W2110113280 hasRelatedWork W2080531066 @default.
- W2110113280 hasRelatedWork W2604872355 @default.
- W2110113280 hasRelatedWork W2748952813 @default.
- W2110113280 hasRelatedWork W2899084033 @default.
- W2110113280 hasRelatedWork W3031052312 @default.
- W2110113280 hasRelatedWork W3032375762 @default.
- W2110113280 hasRelatedWork W3108674512 @default.
- W2110113280 hasVolume "76" @default.
- W2110113280 isParatext "false" @default.
- W2110113280 isRetracted "false" @default.
- W2110113280 magId "2110113280" @default.
- W2110113280 workType "article" @default.